The 25% of FITX to PHOT is for funding from Grow Life and after the license we receive 240million (PHOT) shares. 99% of our share price comes from FITX expected medical cannabis revenue and Hemp Technologies. Any RXNB proprietary agreement with PHOT is a bonus and non-issue. It doesn't effect FITX one bit.


WCB